Harold Eugene Brakewood, Chief Business Officer at Immuneering Corp (IMRX), bought 5,250 shares at $4.76 ($25K) on 2026-01-16, disclosed to the SEC on 2026-01-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |